Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Inari Medical stock

NARI
US45332Y1091
A2P41U

Price

41.24
Today +/-
+0.04
Today %
+0.10 %
P

Inari Medical stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Inari Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Inari Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Inari Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Inari Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Inari Medical Stock Price History

DateInari Medical Price
9/30/202441.24 undefined
9/27/202441.20 undefined
9/26/202440.68 undefined
9/25/202441.48 undefined
9/24/202442.43 undefined
9/23/202443.17 undefined
9/20/202443.68 undefined
9/19/202443.84 undefined
9/18/202444.38 undefined
9/17/202444.10 undefined
9/16/202446.25 undefined
9/13/202446.52 undefined
9/12/202445.95 undefined
9/11/202445.07 undefined
9/10/202444.80 undefined
9/9/202444.64 undefined
9/6/202445.52 undefined
9/5/202441.68 undefined
9/4/202443.08 undefined
9/3/202443.74 undefined

Inari Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Inari Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Inari Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Inari Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Inari Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Inari Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Inari Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Inari Medical’s growth potential.

Inari Medical Revenue, EBIT and net profit per share

DateInari Medical RevenueInari Medical EBITInari Medical Net Income
2028e944.52 M undefined0 undefined0 undefined
2027e1.01 B undefined60.38 M undefined53.49 M undefined
2026e847.92 M undefined43.5 M undefined39.76 M undefined
2025e723.97 M undefined3.93 M undefined13.24 M undefined
2024e612.19 M undefined-25.39 M undefined-43.93 M undefined
2023493.63 M undefined-3.63 M undefined-1.64 M undefined
2022383.5 M undefined-28.1 M undefined-29.3 M undefined
2021277 M undefined10.8 M undefined9.8 M undefined
2020139.7 M undefined18.7 M undefined13.8 M undefined
201951.1 M undefined900,000 undefined-1.2 M undefined
20186.8 M undefined-9.1 M undefined-10.2 M undefined

Inari Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2018201920202021202220232024e2025e2026e2027e2028e
0.010.050.140.280.380.490.610.720.851.010.94
-750.00172.5599.2838.2728.7224.1418.1417.1518.77-6.16
83.3388.2490.6590.9788.5188.03-----
54512625233943400000
-901810-28-3-25343600
-150.00-12.953.61-7.31-0.61-4.080.415.085.96-
-10-1139-29-1-431339530
--90.00-1,400.00-30.77-422.22-96.554,200.00-130.23200.0035.90-
46.146.149.355.652.856.7700000
-----------
Details

Keystats

ⓘ

Revenue and Growth

The Inari Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Inari Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
201820192020202120222023
           
21.823.6164.2176.1326.4115.45
2.211.32842.458.670.12
000000
1.1410.621.132.642.9
0.90.62.95.75.37.09
2639.5205.7245.3422.9235.56
0.93.37.561.472.469.34
00048.31.5
000000
00000150.88
00000214.34
01.80.910.62.62
0.95.18.466.481.3438.67
26.944.6214.1311.7504.2674.24
           
54.254.200.10.10.06
1.42.1227.6257.1462.9504.45
-40.1-41.2-27.4-17.6-46.9-48.49
-0.800-0.40.88.89
000000
14.715.1200.2239.2416.9464.91
0.72.536.57.710.58
1.46.310.83648.565.76
000000
000000
000000
2.18.813.842.556.276.34
9.819.50000
0000036.23
0.21.2029.83196.76
1020.7029.831132.99
12.129.513.872.387.2209.33
26.844.6214311.5504.1674.23
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Inari Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Inari Medical's financial health and stability.

Assets

Inari Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Inari Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Inari Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Inari Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201820192020202120222023
-10-1139-29-1
001346
000000
-1-6-21-14-212
0211526068
001,000000
000035
-10-4125-1335
0-3-5-13-9-6
0-3-55-51-195-58
00-49-37-185-51
000000
09-20000
270164618310
261014441771
----2.00-6.00-9.00
000000
15290-21-32-21
-11.64-8.08-3.5511.84-23.9229.73
000000

Inari Medical stock margins

The Inari Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Inari Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Inari Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Inari Medical's sales revenue. A higher gross margin percentage indicates that the Inari Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Inari Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Inari Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Inari Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Inari Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Inari Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Inari Medical Margin History

Inari Medical Gross marginInari Medical Profit marginInari Medical EBIT marginInari Medical Profit margin
2028e88.03 %0 %0 %
2027e88.03 %6 %5.32 %
2026e88.03 %5.13 %4.69 %
2025e88.03 %0.54 %1.83 %
2024e88.03 %-4.15 %-7.18 %
202388.03 %-0.74 %-0.33 %
202288.4 %-7.33 %-7.64 %
202191.05 %3.9 %3.54 %
202090.69 %13.39 %9.88 %
201988.65 %1.76 %-2.35 %
201880.88 %-133.82 %-150 %

Inari Medical Stock Sales Revenue, EBIT, Earnings per Share

The Inari Medical earnings per share therefore indicates how much revenue Inari Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Inari Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Inari Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Inari Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Inari Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Inari Medical Revenue, EBIT and net profit per share

DateInari Medical Sales per ShareInari Medical EBIT per shareInari Medical Earnings per Share
2028e16.21 undefined0 undefined0 undefined
2027e17.26 undefined0 undefined0.92 undefined
2026e14.55 undefined0 undefined0.68 undefined
2025e12.42 undefined0 undefined0.23 undefined
2024e10.51 undefined0 undefined-0.75 undefined
20238.7 undefined-0.06 undefined-0.03 undefined
20227.26 undefined-0.53 undefined-0.55 undefined
20214.98 undefined0.19 undefined0.18 undefined
20202.83 undefined0.38 undefined0.28 undefined
20191.11 undefined0.02 undefined-0.03 undefined
20180.15 undefined-0.2 undefined-0.22 undefined

Inari Medical business model

Inari Medical Inc. is an American medical technology company founded in 2013 and headquartered in Irvine, California. The company specializes in the development and manufacturing of medical devices for the treatment of vascular diseases. The founders of Inari Medical are Vinayak "Vin" P. Kasabwala and Dr. Thomas "Thom" C. Fogarty. Dr. Fogarty is a well-known pioneer in the field of minimally invasive surgery and has filed more than 160 patents. Both founders have an impressive track record in the development and marketing of medical technology products. Inari Medical's business model is based on the development and marketing of products for the minimally invasive treatment of vascular diseases. The company's goal is to develop medical devices that improve the treatment of these diseases and allow patients to recover faster. Inari Medical is divided into various business units, each specializing in the treatment of different types of vascular diseases. The "VENA" business unit focuses on the treatment of vein diseases such as deep vein thrombosis or blockages of larger veins. The "TROMBUS" business unit is dedicated to the treatment of blood clots in the veins that can be life-threatening. Inari Medical's portfolio includes various medical devices that can be used for this purpose. These include catheters that use ultrasound waves to destroy blood clots without damaging the surrounding tissue. The "PULMUS" business unit specializes in the treatment of pulmonary embolisms, which are blockages of the lung arteries caused by a blood clot. Pulmonary embolisms can be life-threatening and require immediate treatment. Inari Medical Inc. has various products on the market that can be used for the treatment of vascular diseases. These include the ClotTriever thrombectomy catheter, the ClotTriever system, and the FlowTriever system. These products enable fast and effective treatment of vein diseases, blood clots, and pulmonary embolisms. The ClotTriever system is a specially designed catheter that removes compact blood clots that form in the veins and large blood vessels. A special filter system is used to prevent the blood clot from entering other parts of the body. The FlowTriever system, on the other hand, is used for the treatment of pulmonary embolisms. A special catheter is inserted into the pulmonary artery to remove the blood clot and restore blood flow to the lungs. The FlowTriever system is designed to quickly and effectively remove the blood clot without damaging the surrounding tissue. Inari Medical aims to revolutionize the treatment of vascular diseases and enable patients to recover faster. The company has an impressive track record in the development and marketing of medical devices and will continue to offer innovative solutions for the treatment of vascular diseases in the future. Inari Medical is one of the most popular companies on Eulerpool.com.

Inari Medical Revenue by Segment

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Inari Medical Revenue by Segment

Segmente2023
VTE476.28 M USD
Emerging Therapies17.36 M USD

Inari Medical Revenue by Region

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Inari Medical Revenue by Segment

DateInternationalOther CountriesUnited States
202323.77 M USD-469.86 M USD
2022-9.43 M USD374.04 M USD

Inari Medical SWOT Analysis

Strengths

Inari Medical Inc has several strengths that give it a competitive advantage in the market. One of its key strengths is its innovative and advanced medical technologies. The company specializes in developing and manufacturing devices for the treatment of vascular diseases, particularly venous and arterial diseases. This expertise allows Inari Medical Inc to offer cutting-edge solutions to patients and healthcare professionals.

Another strength of Inari Medical Inc is its strong research and development capabilities. The company invests significantly in R&D to continuously improve its existing products and develop new ones. This enables Inari Medical Inc to stay ahead of the competition and provide state-of-the-art medical devices to its customers.

Furthermore, Inari Medical Inc has built a solid reputation as a trusted and reliable brand in the medical device industry. The company's commitment to quality, safety, and efficacy has earned the trust of healthcare professionals and patients alike. This strong brand image gives Inari Medical Inc an advantage when it comes to market penetration and customer loyalty.

Weaknesses

Despite its strengths, Inari Medical Inc also faces certain weaknesses that need to be addressed. One of these weaknesses is its limited geographical presence. Currently, the company primarily operates in the United States. Expanding its reach to other regions and international markets would allow Inari Medical Inc to tap into a larger customer base and increase its market share.

Additionally, as a relatively young company, Inari Medical Inc may lack the financial resources and brand recognition of some of its more established competitors. This could make it harder for the company to compete against larger and more well-known players in the industry.

Opportunities

There are several opportunities that Inari Medical Inc can capitalize on to further grow its business. One significant opportunity is the increasing global prevalence of vascular diseases. As the incidence of conditions such as deep vein thrombosis and pulmonary embolism continues to rise, there is a growing demand for effective treatment options. Inari Medical Inc can leverage its expertise and product offering to capture a larger share of this expanding market.

Furthermore, advancements in medical technology and surgical techniques present opportunities for Inari Medical Inc to develop and introduce new, more efficient devices. By staying at the forefront of innovation, the company can stay ahead of competitors and cater to the evolving needs of healthcare professionals and patients.

Threats

Inari Medical Inc faces certain threats that could impact its business and market position. One major threat is the presence of well-established competitors with extensive resources and established customer bases. These competitors may have the ability to quickly react to market trends and introduce competing products. Inari Medical Inc must continuously innovate and differentiate itself to stay competitive in the face of such threats.

Another potential threat is the stringent regulatory environment surrounding medical devices. Inari Medical Inc must navigate and comply with various regulations and standards, which can incur additional costs and delays in product development and commercialization.

Inari Medical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Inari Medical historical P/E ratio, EBIT multiple, and P/S ratio

Inari Medical shares outstanding

The number of shares was Inari Medical in 2023 — This indicates how many shares 56.771 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Inari Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Inari Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Inari Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Inari Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Inari Medical.

Inari Medical latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.15 -0.38  (-154.01 %)2024 Q2
3/31/2024-0.2 -0.22  (-7.79 %)2024 Q1
12/31/20230.01 -0.08  (-1,411.48 %)2023 Q4
9/30/20230 0.05  (1,011.11 %)2023 Q3
6/30/2023-0.13 0.04  (131.01 %)2023 Q2
3/31/2023-0.23 -0.04  (82.67 %)2023 Q1
12/31/2022-0.17 -0.11  (37.03 %)2022 Q4
9/30/2022-0.26 -0.19  (26.58 %)2022 Q3
6/30/2022-0.23 -0.19  (19.01 %)2022 Q2
3/31/2022-0.09 -0.06  (35.83 %)2022 Q1
1
2

Eulerpool ESG Scorecard© for the Inari Medical stock

Eulerpool World ESG Rating (EESG©)

31/ 100

🌱 Environment

1

👫 Social

40

🏛️ Governance

52

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees42.72
Percentage of women in management—
Percentage of Asian employees21.05
Share of Asian management—
Percentage of Hispanic/Latino employees18.58
Hispano/Latino Management share—
Percentage of Black employees1.93
Black Management Share—
Percentage of white employees55.28
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Inari Medical shareholders

%
Name
Stocks
Change
Date
8.62824 % The Vanguard Group, Inc.5,027,677325,58612/31/2023
7.83135 % Wellington Management Company, LLP4,563,325-532,81112/31/2023
4.85964 % Milder Community Property Trust2,831,714-143,90012/31/2023
4.44768 % Longview Asset Management, L.L.C.2,591,665012/31/2022
4.08380 % AllianceBernstein L.P.2,379,629-18,63212/31/2023
3.74350 % Millennium Management LLC2,181,3371,629,5493/27/2024
3.15936 % State Street Global Advisors (US)1,840,96182,26212/31/2023
2.92108 % Brown Advisory1,702,113255,18212/31/2023
2.01337 % Geode Capital Management, L.L.C.1,173,18854,29012/31/2023
2.00874 % Credit Suisse Funds AG1,170,49414,05312/31/2023
1
2
3
4
5
...
10

Inari Medical Executives and Management Board

Mr. William Hoffman55
Inari Medical Director (since 2015)
Compensation 4.87 M
Mr. Andrew Hykes50
Inari Medical President, Chief Executive Officer, Director (since 2017)
Compensation 3.13 M
Dr. Thomas Tu50
Inari Medical Chief Medical Officer
Compensation 2.32 M
Mr. Mitchell Hill64
Inari Medical Chief Financial Officer
Compensation 2.32 M
Mr. Robert Warner56
Inari Medical Independent Director
Compensation 487,761
1
2
3

Most common questions regarding Inari Medical

What values and corporate philosophy does Inari Medical represent?

Inari Medical Inc is driven by a strong corporate philosophy and a set of core values that define its mission and operations. The company represents a commitment to innovation, patient-centric care, and continuous improvement in the field of medical devices. Inari Medical Inc firmly believes in transforming the lives of patients through its cutting-edge technologies, such as the FlowTriever and ClotTriever systems. With a focus on delivering safe and effective solutions for the treatment of venous and arterial diseases, Inari Medical Inc strives to enhance patient outcomes and provide healthcare professionals with reliable tools. By embracing a patient-first approach and fostering a culture of collaboration and excellence, Inari Medical Inc sets a high standard in the industry.

In which countries and regions is Inari Medical primarily present?

Inari Medical Inc is primarily present in the United States.

What significant milestones has the company Inari Medical achieved?

Inari Medical Inc has achieved several significant milestones since its inception. The company successfully went public in May 2020, listing its shares on the NASDAQ stock exchange under the ticker symbol "NARI". Inari Medical has also developed groundbreaking medical devices, including the FlowTriever and ClotTriever Systems, which offer minimally invasive solutions for the treatment of blood clots. These innovative products have received regulatory approvals and have been adopted by physicians worldwide. In addition, Inari Medical continues to experience rapid growth and expansion, establishing itself as a leader in the field of venous thromboembolism treatment.

What is the history and background of the company Inari Medical?

Inari Medical Inc, founded in 2011, is a leading provider of solutions for the treatment of venous diseases. The company specializes in developing innovative medical devices, particularly for treating blood clots and other vascular conditions. Inari's flagship product, the ClotTriever System, is a minimally invasive device used by physicians to remove clots from blocked vessels, providing a non-surgical alternative to traditional treatments. Inari Medical Inc has experienced significant growth since its inception, driven by the increasing demand for its cutting-edge technologies and a strong focus on improving patient outcomes. With their commitment to revolutionizing venous therapy, Inari Medical Inc continues to drive advancements in the field of vascular intervention.

Who are the main competitors of Inari Medical in the market?

The main competitors of Inari Medical Inc in the market include companies such as Penumbra Inc, Medtronic Plc, and AngioDynamics Inc.

In which industries is Inari Medical primarily active?

Inari Medical Inc is primarily active in the healthcare industry.

What is the business model of Inari Medical?

Inari Medical Inc is a medical device company with a unique business model. The company specializes in developing and commercializing innovative devices for the treatment of venous diseases, specifically deep vein thrombosis (DVT) and pulmonary embolism (PE). Inari Medical Inc's proprietary technologies and products aim to improve patient outcomes by providing minimally invasive solutions for the removal of blood clots. With a focus on research, development, and commercialization of cutting-edge medical devices, Inari Medical Inc aims to revolutionize the treatment of venous diseases and contribute to the improvement of patient care worldwide.

What is the P/E ratio of Inari Medical 2024?

The Inari Medical P/E ratio is -53.3.

What is the P/S ratio of Inari Medical 2024?

The Inari Medical P/S ratio is 3.82.

What is the AlleAktien quality score of Inari Medical?

The AlleAktien quality score for Inari Medical is 2/10.

What is the revenue of Inari Medical 2024?

The expected Inari Medical revenue is 612.19 M USD.

How high is the profit of Inari Medical 2024?

The expected Inari Medical profit is -43.93 M USD.

What is the business model of Inari Medical

Inari Medical Inc. is one of the leading companies in the field of medical technology, focusing on the development and marketing of devices and products for the treatment of vascular and thromboembolic diseases. The business model of Inari Medical is based on the development and marketing of innovative products and services tailored to the needs of patients and physicians. The company operates in two main areas: venous diseases and pulmonary embolism. In the field of venous diseases, Inari Medical offers the ClotTriever System, a unique device for removing blood clots from the deep veins of the body. This system is a non-invasive alternative to traditional surgery, allowing for a minimally invasive procedure. It is a revolutionary procedure that offers benefits such as faster recovery time and high success rate. In the field of pulmonary embolism, Inari Medical has developed the FlowTriever System to remove blood clots from the pulmonary arteries. This system has proven to be effective and offers similar benefits to the ClotTriever System. Both systems are FDA approved and sold worldwide. Inari Medical has also developed a wide range of accessories and consumables to support these devices and improve treatment outcomes. In addition, Inari Medical also offers comprehensive training and education programs for physicians and medical personnel to ensure the safe and effective application of the systems. Inari Medical also has a strong patent portfolio, which has helped to increase its growth and success in the medical industry. The company has obtained several patents for its products and technologies and plans to further expand its portfolio through continuous research and development. Overall, the business model of Inari Medical Inc. has shown that the demand for innovative and effective solutions for the treatment of vascular and thromboembolic diseases is high. Through its reliable products and services, the company has solidified its position as a leading provider of medical technology in the market.

What is the Inari Medical dividend?

Inari Medical pays a dividend of 0 USD distributed over payouts per year.

How often does Inari Medical pay dividends?

The dividend cannot currently be calculated for Inari Medical or the company does not pay out a dividend.

What is the Inari Medical ISIN?

The ISIN of Inari Medical is US45332Y1091.

What is the Inari Medical WKN?

The WKN of Inari Medical is A2P41U.

What is the Inari Medical ticker?

The ticker of Inari Medical is NARI.

How much dividend does Inari Medical pay?

Over the past 12 months, Inari Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Inari Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Inari Medical?

The current dividend yield of Inari Medical is .

When does Inari Medical pay dividends?

Inari Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Inari Medical?

Inari Medical paid dividends every year for the past 0 years.

What is the dividend of Inari Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Inari Medical located?

Inari Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Inari Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Inari Medical from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Inari Medical pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Inari Medical in the year 2023?

In the year 2023, Inari Medical distributed 0 USD as dividends.

In which currency does Inari Medical pay out the dividend?

The dividends of Inari Medical are distributed in USD.

All fundamentals about Inari Medical

Our stock analysis for Inari Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Inari Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.